Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Circ Res. Author manuscript; available in PMC 2010 August 23.
Published in final edited form as:
PMCID: PMC2925175

Connexin40 Imparts Conduction Heterogeneity to Atrial Tissue


Impulse propagation in cardiac tissue is a complex process in which intercellular coupling through gap junction channels is a critical component. Connexin40 (Cx40) is an abundant gap junction protein that is expressed in atrial myocytes. Alterations in the expression of Cx40 have been implicated in atrial arrhythmogenesis. The purpose of the current study was to assess the role of Cx40 in atrial impulse propagation. High-resolution optical mapping was used to study conduction in the right and left atrial appendages of isolated Langendorff-perfused murine hearts. Wild-type (Cx40+/+), heterozygous (Cx40+/−), and knockout (Cx40−/−) mice, both adult and embryonic, were studied to assess the effects of reduced Cx40 expression on sinus node function and conduction velocity at different pacing cycle lengths (100 and 60 ms). In both adult and late-stage embryonic Cx40+/+ mice, heterogeneity in CV was found between the right and left atrial appendages. Either partial (Cx40+/−) or complete (Cx40−/−) deletion of Cx40 was associated with the loss of conduction heterogeneity in both adult and embryonic mice. Additionally, sinus node impulse initiation was found to be ectopic in Cx40−/− mice at 15.5 days postcoitus, whereas Cx40+/+ mice showed normal activation occurring near the crista terminalis. Our findings suggest that Cx40 plays an essential role in establishing interatrial conduction velocity heterogeneity in the murine model. Additionally, we describe for the first time a developmental requirement for Cx40 in normal sinus node impulse initiation at 15.5 days postcoitus.

Keywords: arrhythmia, conduction velocity, Cx40, optical mapping, sinus node

Cardiac myocytes are connected electrically and metabolically through gap junction channels.1 A complete channel is composed of 2 opposing hexameric structures or connexons, each consisting of 6 protein subunits called connexins.2 At least 3 connexins are expressed in cardiac myocytes: connexin40 (Cx40), connexin43 (Cx43), and connexin45 (Cx45), each forming channels with unique electrophysiological and biophysical properties.3,4 Within the adult heart, connexin isoforms have distinct patterns of expression, which are generally well preserved among different species. Cx40 is expressed predominantly in atrial myocytes and in the ventricular conduction system; Cx43 is expressed in both atrial and ventricular myocytes; Cx45 is expressed mainly in the sinoatrial node, anteroventral node, and in the ventricular conduction system, with lower levels reported in the atrial myocardium.

Alterations in the expression of connexin proteins have been described in a variety of pathological conditions in both animal5 and human models.6,7 However, most studies that have investigated the importance of connexins have focused on ventricular conduction, whereas relatively few studies are available directly addressing their role in mediating atrial impulse initiation and propagation. Studies investigating the role of Cx40 in atrial arrhythmogenesis have found highly variable levels of expression.814 Conflicting results have also been reported with respect to the electrophysiological effects of Cx40 deletion on impulse conduction.15,16

The lack of uniformity of these findings may be attributable, at least in part, to model-specific parameters. The purpose of the present study was to conduct a comprehensive investigation into the role of Cx40 in mediating impulse initiation and propagation in the intact mouse atria. To achieve this goal, we investigated atrial impulse initiation and chamber-specific conduction parameters in Cx40-deficient animals during embryonic development and over a wide range of ages. Our findings suggest an important role for Cx40 in establishing the site of impulse initiation during embryonic development and conduction heterogeneity within the atrial myocardium.

Materials and Methods


All procedures were approved by the New York University School of Medicine Institutional Animal Care and Use Committee. Forty-nine adult (aged 2 to 11 weeks) and 80 embryonic mice (13.5 to 15.5 days postcoitus [dpc]) were included in this study. Interbreeding of the appropriate mice was performed to obtain heterozygous (Cx40+/−) and knockout (Cx40−/−) genotypes. Genotyping was performed using polymerase chain reaction (PCR) with genomic DNA extracted from tail tips as previously described.17 Wild-type (Cx40+/+) littermates were used as controls. The background strain of the mice was C57BL/6. Mice showing visible morphological abnormalities were excluded from the study (see supplemental material).

Optical Mapping Studies

Details for the adult and embryonic heart isolation and perfusion are provided in the supplemental material. High-resolution optical mapping studies of adult atrial appendages were performed using an upright microscope (BX-51WI; Olympus Inc) equipped with a high-speed charge-coupled device camera (Dalsa Inc, Waterloo, Canada). Excitation light from a 100-W mercury arc lamp was passed through an interference filter (470±30 nm) together with a dichroic mirror (500 nm). The emitted fluorescent light was split with a second dichroic mirror (600 nm) and simultaneously collected at 2 wavelengths (550±40 nm and >610 nm) using 2 synchronized and registered charge-coupled device video cameras. Image registration of the 2 cameras was verified at the beginning of each experiment using custom image registration software. This software provided an online image in which differences between the 2 cameras were displayed. One of the cameras was mounted on a 3-dimensional manipulator, which was adjusted to minimize differences between the 2 cameras. The cameras were considered registered when the images recorded on the cameras differed by less than one pixel. Recordings were made in the bin mode, which allowed for an array of 64×64 pixels to be acquired at 947 frames/s with 12-bit resolution. Imaging of the right and left atrial appendages (RAA, LAA, respectively) were carried out with either a 2× or 4× objective (spatial resolution 122 and 62.5 µm/pixel, respectively) in the absence of any pharmacological or mechanical motion-reduction techniques. Distortion due to curvature of tissue was minimized by orienting the atrial appendages parallel to the objective lens. Regions outside of the focal plane were excluded. Pseudoelectrocardiograms were calculated as the average pixel intensity for each frame and plotted as a function of time.

Embryonic hearts were illuminated with excitation light from a 100-W mercury arc lamp passed through an interference filter (530±40 nm) together with a dichroic mirror (565 nm). The fluorescent light (>610 nm) emitted from the right and left atria was collected and projected onto a CMOS video camera (Ultima-L; SciMedia, Inc). Recordings were obtained at 1000 frames/s with a 100×100 pixel array at 14-bit resolution. Imaging studies were performed using 5×, 8×, and 10× objectives resulting in spatial resolution ranging from 20 to 40 µm/pixel.

Volume-Conducted Electrocardiograms

A bipolar electrode mounted on a micromanipulator was used to record biatrial electrograms from isolated hearts. Recordings were made using Ag-AgCl electrodes placed approximately 1 to 2 mm from the heart surface. Electrograms were amplified, low pass-filtered at 300 Hz (CyberAmp; Axon Instruments), and digitally sampled at 5 kHz using an A/D digitizer (Digidata; Axon Instruments, Inc) and a commercially available software package (Axo-Scope; Axon Instruments, Inc). Continuous recordings were obtained through the entire experiment and stored for offline analysis. Recordings were electronically tagged to indicate when the hearts were paced and optically mapped.

Pacing of Murine Atrial Appendages

Average epicardial conduction velocity (CV) measurements were obtained by separately pacing the RAA and LAA (Figure 1A–C) with a platinum monopolar electrode (250 µm tip diameter; FHC Inc, Catalog #UE[GM1]). Details of the methods used to calculate CV are provided in the supplemental material. The appendages were paced at basic cycle lengths of 100 and 60 ms using pulses 2 ms in duration at 1.5 times diastolic threshold. This current amplitude was used to minimize virtual electrode effects. Activity during pacing was recorded for 2 seconds.

Figure 1
Pacing sites, conduction patterns, and single pixel recordings from the left atrial appendage. A, Schematic of the atria showing the pacing sites on the RAA and LAA and the imaged area (box). B, Brightfield image of the LAA of a Cx40+/+ mouse. C, Optical ...

RNA Quantification

Total RNA was isolated using Trizol and quantified through spectro-photometry. Quantitative real-time PCR (qRT-PCR, ABI Prism 7700 Sequence Detection System; Applied Biosystems, Foster City, Calif) was used to determine the mRNA levels of Cx40, Cx43, and cyclophilin A. Detection of amplification is contingent on the specific hybridization of the fluorogenic probe and the flanking forward and reverse primers. The primer sequences for Cx40 and Cx43 were as follows: Cx40 forward primer: ATTCTGATCCGCACCACCAT; Cx40 reverse primer: CATGCAGGGTATCCAGGA AGA; Cx40 Taqman probe: TGGCCTTCATCGTAGGCCAGTACCTCC; Cx43 forward primer: TGAAGGGAAGAAGCGATCCTT, Cx43 reverse primer: GGAGATCCGCAGTCT TTGGA; and Cx43 Taqman probe: ACGCCACCACCGGCCCACT.

The probe, labeled at the 5′ and 3′ ends with 6-carboxyfluorescein reporter and 6-carboxytetramethylrhodamine quencher, respectively, is hydrolyzed by the 5′ exonuclease activity of Taq DNA polymerase causing an increase in fluorescent signal that is measured in real time after each cycle of PCR amplification. Fluorescence thresholds were set to 10 standard deviations above baseline fluorescence. Standard curves were constructed by plotting log10 RNA starting quantity versus cycle threshold. On the basis of appropriate serially diluted standard RNA, the amount of input standard RNA yielding the same amount of PCR product measured from an unknown sample was calculated. Measured RNA levels were normalized to cyclophilin A and expressed as a ratio of the gene of interest (ie, Cx40/cyclophilin A).18,19


Hearts were flash-frozen in liquid nitrogen and stored at −20°C. The tissue was later thawed and embedded in OCT before sectioning. Frozen sections were fixed in acetone followed by immunostaining. 20 Sections were acquired to generate RAA and right atria, or LAA and left atria, or RAA and LAA of each heart in the same section for comparison. The primary antibodies used were the polyclonal anti-Cx40 available from Alpha Diagnostic and the monoclonal anti-Cx43 available from Zymed (Clone 3D8A5, Catalog#35–5000). Secondary antibodies Alexa594-conjugated antirabbit and fluorescein isothiocyanate conjugated goat antimouse IgG (Jackson ImmunoResearch Laboratories) were used, respectively. Sections were visualized with an Axioskop 2 Plus fluorescence microscope (Carl Zeiss, Munchen-Hallbergmoos, Germany). Samples processed without primary antibody served as negative controls. Colocalization methods are provided in the supplemental material.

Western Blot Analysis

A subset of optically imaged hearts (11 young and 11 adult) was examined by Western blot analysis. After the imaging studies, the hearts were flash-frozen in liquid nitrogen and stored at −20°C. To prepare samples, the hearts were later thawed, RAA and LAA isolated, and each manually Dounce-homogenized on ice in 50 mL of radioimmunoprecipitation buffer (20 mmol/L Tris, pH 7.4; 0.15 mol/L NaCl; 1% Triton X-100; 0.1% SDS) with 1 µL protease inhibitors, 1 µL 0.1 mol/L NaVO3, and 2.5 µL NaF. After tissue lysis, the samples were spun for 1 minute at 4°C and the supernatant was collected. Protein concentrations of each sample were measured using the Lowrly method. Equal volumes of 2× SDS-PAGE loading buffer were added to the calculated volume of 5 µg of protein per sample and boiled at 95°C for 2 minutes. The final volumes of each atrial appendage sample were loaded on the premade linear 4% to 15% gradient gels (BioRad). Gels were run at a constant voltage of 100 V and transferred to nitrocellulose membrane using a constant current of 0.2 A (BioRad power supply). After blocking with 5% nonfat dry milk in Tris-buffered saline containing 0.05% Tween-20 for 1 hour at room temperature, membranes were washed and incubated with 1:5000 rabbit polyclonal anti-Cx43 antibody overnight at 4°C. The rabbit polyclonal anti-Cx43 antibody (custom manufactured by Research Genetics, Huntsville, Ala) was directed against the same epitope used by Yamamoto and colleagues.21 Membranes were then treated with 1:1000 horseradish peroxidase-conjugated secondary goat antirabbit antibody (Jackson ImmunoResearch Laboratories). For loading controls and normalization, the same membranes were reblocked with 5% nonfat dry milk in Tris-buffered saline containing 0.05% Tween-20, washed, and incubated with monoclonal anti-GAPDH antibodies (1:300) overnight at 4°C and subsequently blotted with antimouse secondary antibody. Immunoreactive proteins were visualized using chemiluminescent processing (ECL; Amersham Pharmacia Biotech) and autoradiography by exposure to Eastman Kodak X-AR films. Densitometry measurements of Cx43 protein levels were compared between RAA and LAA within each genotype, and between genotypes for RAA and LAA separately, for each age group using NIH ImageJ software.

Statistical Analysis

Statistical analysis was carried out with the Microsoft Excel software package. Values are reported as mean±SEM. Power analysis was used to determine the minimum detectable differences in CV measurements during the initial studies. When appropriate, statistical analysis was performed using analysis of variance or 2-tailed paired Student t test with P<0.05 considered significant. The Bonferroni correction was used to minimize Type I error when multiple statistical tests were performed using the same data set. Regression analyses were performed using a least-squares analysis in which the null hypothesis is confirmed when the slope is equal to zero.


Optical Mapping of Adult Hearts

Representative atrial appendage activation maps are shown in Figure 2 for Cx40+/+ (Figures 2A, D), Cx40+/− (Figures 2B, E), and Cx40−/− (Figures 2C, F) mice. Average CVs measured at basic cycle length 100 ms are shown in Figure 2G. Similar results were obtained at basic cycle length 60 ms (data not shown). In Cx40+/+ mice, average CV in the LAA was significantly faster than in the RAA (0.63±0.004 and 0.53±0.004 m/s, respectively, at basic cycle length 100 ms, P=0.002; 0.61±0.004 and 0.51±0.004 m/s, respectively, at basic cycle length 60 ms, P=0.001). In both the heterozygous and homozygous Cx40-deficient mice, differences in CVs between right and left atria were not found, indicating a loss of heterogeneity of CV in the Cx40-deficient atria. When CV was compared between mice of different genotypes, Cx40+/− mice were found to have slower LAA CV compared with Cx40+/+ mice (P<0.01). All other CVs were not significantly different between mice of different genotypes.

Figure 2
Activation maps and conduction velocities from right and left atrial appendages in adult mice. A–F, Representative activation maps recorded from the RAA and LAA showing chamber-specific heterogeneity in activation times of the Cx40+/+ and the ...

Cx40 and Cx43 Expression

Analysis of Cx40 and Cx43 mRNA levels by qRT-PCR was performed to determine whether connexin mRNA levels correlate with chamber-specific CV differences (Figure 3A–B). In the Cx40+/+ mice, significant right–left heterogeneity in Cx40 mRNA expression was detected with higher levels of mRNA being expressed in the LAA compared with RAA (P=0.03). This right–left heterogeneity in mRNA expression was lost in the Cx40+/− mice. Cx40 mRNA expression was significantly reduced in the Cx40+/− mice compared with the Cx40+/+ mice in both the RAA (P<0.001) and LAA (P=0.001). Cx43 mRNA was not found to be heterogeneously expressed in the RAA and LAA of Cx40+/+, Cx40+/−, or Cx40−/− mice, nor were differences in Cx43 mRNA expression detected in mice of different genotypes. These data suggest that the CV heterogeneity detected in Cx40+/+ mice and the loss of CV heterogeneity detected in Cx40 mutants can be explained by heterogeneity in Cx40 mRNA expression.

Figure 3
Cx40 and Cx43 mRNA and protein levels. A, Cx40 mRNA expression in Cx40+/+ (n=6) and Cx40+/− (n=5) adult mice showing heterogeneity in the Cx40+/+ mice and the lack of heterogeneity in the Cx40+/− mice. B, Cx43 mRNA expression in Cx40+/+ ...

Analysis of Cx40 protein levels was performed to determine whether gradients in Cx40 expression were present in the mouse atria (Figure 3C). Visual inspection comparing samples of Cx40+/+ mice revealed no overt right–left differences. Immunostaining of Cx43 was also performed in both Cx40+/+ and Cx40−/− mice to exclude the possibility of compensatory changes in Cx43 (Figure 3D). Cx43 expression did not appear altered in the Cx40−/− compared with the Cx40+/+ mice nor were right–left differences detected in mice of either genotype. Finally, colocalization of Cx40 and Cx43 immunosignal by immunofluorescence microscopy was evaluated and no statistical differences between the right and left atria of Cx40+/+ mice were identified (data not shown).

Next, Cx40 protein expression was quantified by Western blotting (Figure 3E–F). Although there was a trend toward greater Cx40 protein expression in the LAA compared with the RAA in both Cx40+/+ and Cx40+/− mice, these values were not significantly different. Significantly reduced expression of Cx40 was found in Cx40+/− compared with Cx40+/+ mice in both the RAA and LAA (P>0.05).

Age Dependence

Regression analysis was performed comparing age (in days) versus right–left CV differences to determine if CV heterogeneity was age-dependent. The heterogeneity of CVs in Cx40+/+ mice was not found to be associated with age. Similarly, the loss of heterogeneity in Cx40+/− and Cx40−/− mice did not show age-dependent changes.

Optical Mapping of Embryonic Hearts

Next, we investigated whether the heterogeneity observed in Cx40+/+ adult mice was also present in embryonic mice. As shown in Figure 4, mice at 15.5 dpc demonstrated a similar pattern to the adults with CV heterogeneity found in Cx40+/+ mice and lost in Cx40+/− and Cx40−/− mice. However, unlike their adult counterparts, CV heterogeneity in embryonic Cx40+/+ mice was established by faster RAA CV relative to the LAA. Although there appears to be some heterogeneity in CV in the embryonic Cx40−/− mice, this difference was not significant and is likely attributable to difficulty in measuring CV in embryonic hearts due to their small size, greater curvature of tissue, and variations in heart rate. Interestingly, no right–left heterogeneity was seen in Cx40+/+ mice at 13.5 dpc (data not shown), suggesting that this narrow period of time between 13.5 and 15.5 dpc may represent an important window during which Cx40 contributes to the development of interatrial CV heterogeneity.

Figure 4
Activation maps and conduction velocities from embryonic mice during normal sinus rhythm. A–F, Representative activation maps recorded from the right (RA) and left atria (LA) showing heterogeneity of activation times in the Cx40+/+ and the lack ...

Impulse Initiation in the Embryonic Heart

Given our findings suggesting that the development of CV heterogeneity in Cx40+/+ mice is a Cx40-dependent process occurring as early as 15.5 dpc, we next investigated whether Cx40 also influenced the site of sinus node impulse initiation in embryonic mice. Figure 5A–D shows representative color maps of dF/dt activity during normal sinus rhythm, whereas Figure 5E–H is a schematic indicating the site of impulse initiation in Cx40+/+ and Cx40−/− mice at 13.5 and 15.5 dpc. At 13.5 dpc, both Cx40+/+ and Cx40−/− mice showed normal sinus node activation originating near the crista terminalis. At 15.5 dpc, normal sinus node activation was maintained in Cx40+/+ mice but was lost in Cx40−/− mice with atrial impulse initiation occurring at multiple ectopic sites, including both appendages and the left atrial myocardium. Additionally, the site of impulse initiation often varied from beat to beat. These data suggest that there is a developmental requirement of Cx40 between 13.5 and 15.5 dpc for normal impulse initiation in the sinus node region.

Figure 5
Impulse initiation in Cx40-deficient embryonic mice. A–D, Representative dF/dt activity maps for Cx40+/+ mice at 13.5 dpc (A), Cx40−/− mice at 13.5 dpc (B), Cx40+/+ mice at 15.5 dpc (C), and Cx40−/− mice at 15.5 ...


Although Cx40 has been implicated in mediating cardiac arrhythmogenesis, its exact role in this respect is not fully understood. The principal findings of this study are: 1) both adult and embryonic Cx40+/+ mice exhibit interatrial CV heterogeneity with the right and left atria conducting at significantly different velocities; 2) this heterogeneity in CV between the atrial chambers is lost with complete or partial (heterozygous) deletion of Cx40 in both adult and embryonic mice; 3) Cx40 mRNA levels showed significant interatrial heterogeneity in Cx40+/+ mice with higher levels in the adult LAA compared with RAA; 4) this heterogeneity in Cx40 mRNA expression was lost with partial or complete deletion of Cx40; 5) the interatrial CV heterogeneity seen in embryonic (and then later in adult) Cx40+/+ mice is absent at 13.5 dpc and develops by 15.5 dpc; and 6) development of normal sinus node impulse initiation is independent of Cx40 expression at 13.5 dpc and becomes dependent by 15.5 dpc. These findings demonstrate for the first time that Cx40 imparts interatrial CV heterogeneity in Cx40+/+ adult and embryonic mice. Furthermore, there is a developmental requirement of Cx40 for normal impulse initiation to occur within the sinus node region.

Several important aspects of this study contribute to our understanding of the role Cx40 plays in atrial conduction heterogeneity. This is the first study to include mice from a wide range of ages, allowing for comparisons between embryonic and adult mice. Additionally, CV was quantified at each stage in a chamber-specific manner allowing for the detection of regionally specific effects of Cx40 deletion. Finally, morphologically abnormal hearts were excluded from this study. Studies have found the incidence of major cardiac malformations in Cx40-deficient mice to be as high as 33% with such malformations including tetralogy of Fallot, double-outlet right ventricle, endocardial cushion defects,22 cardiac hypertrophy, and ventricular septal defects.23 In addition, unique defects in mice doubly deficient in 3 different cardiac connexins have been reported.24,25 The high rate and variability of morphological anomalies seen in connexin-deficient mice raises the possibility that inclusion of such animals could influence analysis of impulse initiation and conduction parameters. Although additional work is needed to determine whether anatomic changes can lead to functional changes in CV, preliminary experiments in our laboratory using morphologically abnormal Cx40-deficient hearts support this idea. These hearts showed decreased atrial CV compared with morphologically normal age-matched controls (0.48±0.16 versus 0.57±0.09 m/s, respectively; n=3).

Animal and human studies that have investigated the relation between atrial fibrillation and Cx40 expression have found conflicting results.814 Additionally, evidence of an association between pacing-induced atrial fibrillation in goats and the development of multiple small areas of atrial tissue deficient in Cx40 suggests that Cx40 expression itself may be influenced by chronic exposure to arrhythmias.26 From these studies it seems likely that remodeling of Cx40 is highly dependent on model-specific parameters and more work is needed to determine the underlying factors that influence connexin expression. Prior studies have also found conflicting results related to the effects of Cx40 deletion on atrial CV. A recent study reported faster CVs are associated with reduced expression of Cx40 in neonatal atrial myocyte monolayers.15 Conversely, Cx40 deletion has been shown to slow CV in the right atrial free wall during epicardial pacing in intact adult murine atria.16 Together, these studies suggest Cx40’s role in mediating normal and abnormal atrial impulse propagation may vary depending on age and/or structural parameters. The difference in the direction of interatrial heterogeneity between embryonic and adult hearts supports a concept of a change in the role of Cx40 with time. The mechanism underlying the directional changes in CV heterogeneity that occur with age may also be related to the relative expression levels of Cx40 and Cx43. Although the expression of levels of Cx40 in the atria has not been systematically studied in postnatal life, Cx43 expression has been shown to increase with age.27

Interatrial CV heterogeneity dependence on Cx40 could be explained by heterogeneity in Cx40 expression. Although Western blot and immunohistological analysis did not demonstrate significant right–left differences in Cx40 protein expression in the Cx40+/+ mice, quantification of Cx40 mRNA expression found chamber-specific differences that followed a similar pattern to the CV findings. It is recognized that qRT-PCR is an assay that is less variable than Western blot.28 Heterogeneity in Cx40 mRNA expression (LAA>RAA) was detected in Cx40+/+ mice and lost with partial deletion of Cx40, mirroring CV findings.

Variations in connexin expression likely play an important role in the development of atrial arrhythmias associated with both structural heart disease and normal aging.29,30 Our findings could explain an increased incidence of arrhythmias through at least 3 mechanisms. First, because cardiac disease and human polymorphisms of Cx40 would be unlikely to result in the complete absence of Cx40 expression, the heterozygous (Cx40+/−) mouse is likely to be a more realistic model. The current study found that heterozygous deletion of Cx40 resulted in significant slowing of LAA CV in adult mice. Such slowing of CV within the left atrium could act as a substrate for increased arrhythmic propensity humans. Given the arrhythmogenic potential of the pulmonary vein region, changes in Cx40 expression in this area may have important clinical implications. The second possibility relates to the interatrial heterogeneity found in the Cx40+/+ mice, which was lost in Cx40+/− and Cx40−/− mice. It is possible that overexpression of Cx40 could contribute to greater heterogeneity than that observed in the Cx40+/+ mice. Although this interpretation is an extrapolation of our findings, the importance of electrophysiological heterogeneities in mediating cardiac arrhythmogenesis is well established.31 Increased CV heterogeneity with overexpression of Cx40 could increase the likelihood of significant arrhythmogenic events, consistent with human studies demonstrating a link between Cx40 upregulation and atrial fibrillation.9,10 Finally, it is possible that the interatrial CV heterogeneities found in this study may be amplified in larger animals. Because myocyte size is relatively stable across different species, greater numbers of gap junction channels are recruited during electric propagation as heart size is increased. Consequently, changes in Cx40 expression may have a greater impact on CV in larger hearts. Future studies are needed to better understand the complex interplay among cardiac connexin isoforms, CV, and arrhythmogenesis.

Supplementary Material



Sources of Funding

This work was supported by a grant (HL76751) to GEM from the National Institutes of Health Heart Lung and Blood Institute and a postdoctoral fellowship award to CV from the American Heart Association.


Reprints: Information about reprints can be found online at




1. Kleber AG, Fast VG, Rohr S. Continuous and discontinuous propagation. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders Co; 2000. pp. 205–213.
2. Moreno AP. Biophysical properties of homomeric and heteromultimeric channels formed by cardiac connexins. Cardiovasc Res. 2004;62:276–286. [PubMed]
3. Saffitz JE, Lerner DL, Yamada KA. Gap junction distribution and regulation in the heart. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology: From Cell to Bedside. Vol IV. Philadelphia: WB Saunders; 2004. pp. 181–191.
4. Jalife J, Morley GE, Vaidya D. Connexins and impulse propagation in the mouse heart. J Cardiovasc Electrophysiol. 1999;10:1649–1663. [PubMed]
5. Luke RA, Saffitz JE. Remodeling of ventricular conduction pathways in healed canine infarct border zones. J Clin Invest. 1991;87:1594–1602. [PMC free article] [PubMed]
6. Smith JH, Green CR, Peters NS, Rothery S, Severs NJ. Altered patterns of gap junction distribution in ischemic heart disease: an immunohisto-chemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol. 1991;139:801–821. [PubMed]
7. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation. 1993;88:864–875. [PubMed]
8. Kanagaratnam P, Peters NS. Conduction, gap junctions, and atrial fibrillation: an eternal triangle? Heart Rhythm. 2004;1:746–749. [PubMed]
9. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-Regnier F, De Vivie ER, Dhein S. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol. 2001;38:883–891. [PubMed]
10. Dupont E, Ko Y, Rothery S, Coppen SR, Baghai M, Haw M, Severs NJ. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation. 2001;103:842–849. [PubMed]
11. Kirchhoff S, Nelles E, Hagendorff A, Kruger O, Traub O, Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol. 1998;8:299–302. [PubMed]
12. Verheule S, van Batenburg CA, Coenjaerts FE, Kirchhoff S, Willecke K, Jongsma HJ. Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40. J Cardiovasc Electrophysiol. 1999;10:1380–1389. [PubMed]
13. Nao T, Ohkusa T, Hisamatsu Y, Inoue N, Matsumoto T, Yamada J, Shimizu A, Yoshiga Y, Yamagata T, Kobayashi S, Yano M, Hamano K, Matsuzaki M. Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol. 2003;91:678–683. [PubMed]
14. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res. 2002;54:361–379. [PubMed]
15. Beauchamp P, Yamada KA, Baertschi AJ, Green K, Kanter EM, Saffitz JE, Kleber AG. Relative contributions of connexins 40 and 43 to atrial impulse propagation in synthetic strands of neonatal and fetal murine cardiomyocytes. Circ Res. 2006;99:1216–1224. [PubMed]
16. Bagwe S, Berenfeld O, Vaidya D, Morley GE, Jalife J. Altered right atrial excitation and propagation in connexin40 knockout mice. Circulation. 2005;112:2245–2253. [PMC free article] [PubMed]
17. Simon AM, Goodenough DA, Paul DL. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol. 1998;8:295–298. [PubMed]
18. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, Tacke F, Randolph GJ, Fisher EA. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci U S A. 2006;103:3781–3786. [PubMed]
19. Rong JX, Shapiro M, Trogan E, Fisher EA. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci U S A. 2003;100:13531–13536. [PubMed]
20. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, Fishman GI. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res. 2001;88:333–339. [PMC free article] [PubMed]
21. Yamamoto T, Ochalski A, Hertzberg EL, Nagy JI. LM and EM immunolocalization of the gap junctional protein connexin 43 in rat brain. Brain Res. 1990;508:313–319. [PubMed]
22. Gu H, Smith FC, Taffet SM, Delmar M. High incidence of cardiac malformations in connexin40-deficient mice. Circ Res. 2003;93:201–206. [PubMed]
23. Kirchhoff S, Kim JS, Hagendorff A, Thonnissen E, Kruger O, Lamers WH, Willecke K. Abnormal cardiac conduction and morphogenesis in connexin40 and connexin43 double-deficient mice. Circ Res. 2000;87:399–405. [PubMed]
24. Simon AM, McWhorter AR, Dones JA, Jackson CL, Chen H. Heart and head defects in mice lacking pairs of connexins. Dev Biol. 2004;265:369–383. [PubMed]
25. Kretz M, Eckardt D, Kruger O, Kim JS, Maurer J, Theis M, van Rijen HV, Schorle H, Willecke K. Normal embryonic development and cardiac morphogenesis in mice with Wnt1-Cre-mediated deletion of connexin43. Genesis. 2006;44:269–276. [PubMed]
26. van der Velden HM, van Kempen MJ, Wijffels MC, van Zijverden M, Groenewegen WA, Allessie MA, Jongsma HJ. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol. 1998;9:596–607. [PubMed]
27. Fishman GI, Hertzberg EL, Spray DC, Leinwand LA. Expression of connexin43 in the developing rat heart. Circ Res. 1991;68:782–787. [PubMed]
28. Bearden SE, Linn E, Ashley BS, Looft-Wilson RC. Age-related changes in conducted vasodilation: effects of exercise training and role in functional hyperemia. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1717–R1721. [PubMed]
29. Spach MS, Heidlage JF, Dolber PC, Barr RC. Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth. Circ Res. 2000;86:302–311. [PubMed]
30. Kanno S, Saffitz JE. The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol. 2001;10:169–177. [PubMed]
31. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, Lima JA, Wu KC. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115:2006–2014. [PMC free article] [PubMed]